Klaus Starke

607 total citations
18 papers, 548 citations indexed

About

Klaus Starke is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Klaus Starke has authored 18 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Klaus Starke's work include Adenosine and Purinergic Signaling (10 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Klaus Starke is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Ion channel regulation and function (5 papers) and Receptor Mechanisms and Signaling (5 papers). Klaus Starke collaborates with scholars based in Germany. Klaus Starke's co-authors include Ralph Bültmann, Ivar von Kügelgen, Bernd Driessen, Katharina Kurz, Anne‐Ulrike Trendelenburg, Gerhard J. Molderings, Florin Tuluc, Georg Hansmann, N. Limberger and Béla Szabó and has published in prestigious journals such as British Journal of Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology and Journal of Cardiovascular Pharmacology.

In The Last Decade

Klaus Starke

18 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Starke Germany 14 337 312 201 115 115 18 548
D.J. Trezise United Kingdom 11 194 0.6× 217 0.7× 147 0.7× 139 1.2× 133 1.2× 15 436
Chaoying Li United States 7 191 0.6× 143 0.5× 167 0.8× 94 0.8× 32 0.3× 7 355
J. Crist United States 9 203 0.6× 77 0.2× 248 1.2× 127 1.1× 115 1.0× 12 550
Angelika Meyer Germany 11 187 0.6× 118 0.4× 163 0.8× 82 0.7× 44 0.4× 16 348
M. Ballarín Spain 10 166 0.5× 190 0.6× 224 1.1× 36 0.3× 36 0.3× 14 414
Sylvester E. Vizi Hungary 8 176 0.5× 75 0.2× 266 1.3× 54 0.5× 57 0.5× 16 417
Melanie Alexis Ruiz Spain 11 109 0.3× 223 0.7× 140 0.7× 63 0.5× 30 0.3× 18 347
S D Collins United Kingdom 7 148 0.4× 56 0.2× 160 0.8× 35 0.3× 262 2.3× 14 452
Laura Oliveira Portugal 13 223 0.7× 142 0.5× 185 0.9× 24 0.2× 36 0.3× 19 433
Nadine Evers Germany 7 83 0.2× 47 0.2× 57 0.3× 167 1.5× 196 1.7× 7 404

Countries citing papers authored by Klaus Starke

Since Specialization
Citations

This map shows the geographic impact of Klaus Starke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Starke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Starke more than expected).

Fields of papers citing papers by Klaus Starke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Starke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Starke. The network helps show where Klaus Starke may publish in the future.

Co-authorship network of co-authors of Klaus Starke

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Starke. A scholar is included among the top collaborators of Klaus Starke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Starke. Klaus Starke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Koch, Helga, Ivar von Kügelgen, & Klaus Starke. (1998). P2-Receptor-mediated inhibition of noradrenaline release in the rat pancreas. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(4). 431–440. 13 indexed citations
2.
Trendelenburg, Anne‐Ulrike, et al.. (1997). A re-investigation of questionable subclassifications of presynaptic α2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(6). 721–737. 60 indexed citations
3.
Hansmann, Georg, Ralph Bültmann, Florin Tuluc, & Klaus Starke. (1997). Characterization by antagonists of P2-receptors mediating endothelium-dependent relaxation in the rat aorta. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(5). 641–652. 31 indexed citations
4.
Trendelenburg, Anne‐Ulrike, N. Limberger, & Klaus Starke. (1995). Subclassification of presynaptic ?2-adrenoceptors: ?2D-autoreceptors in guinea-pig atria and brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(1). 49–57. 20 indexed citations
5.
Driessen, Bernd, et al.. (1995). Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue. Naunyn-Schmiedeberg s Archives of Pharmacology. 351(5). 555–60. 28 indexed citations
6.
Starke, Klaus, et al.. (1995). Reactive red 2: a P2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(5). 477–82. 27 indexed citations
7.
Driessen, Bernd & Klaus Starke. (1994). Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(6). 618–25. 17 indexed citations
8.
Bültmann, Ralph & Klaus Starke. (1994). Blockade by 4,4′‐diisothiocyanatostilbene‐2,2′‐disulphonate (DIDS) of P2X‐purinoceptors in rat vas deferens. British Journal of Pharmacology. 112(2). 690–694. 46 indexed citations
9.
Kurz, Katharina, et al.. (1994). P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(2). 125–132. 43 indexed citations
10.
Bültmann, Ralph, et al.. (1994). Blockade of P2X‐purinoceptors by trypan blue in rat vas deferens. British Journal of Pharmacology. 113(2). 349–354. 21 indexed citations
11.
Starke, Klaus, et al.. (1993). Evans blue blocks P2X-purinoceptors in rat vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(6). 684–687. 36 indexed citations
12.
Kurz, Katharina, et al.. (1993). Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1‐ and P2‐purinoceptors. British Journal of Pharmacology. 110(4). 1465–1472. 53 indexed citations
13.
Driessen, Bernd, Ivar von Kügelgen, & Klaus Starke. (1993). Neural ATP release and its α2-adrenoceptor-mediated modulation in guinea-pig vas deferens. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(4). 358–366. 64 indexed citations
14.
Driessen, Bernd, Ralph Bültmann, Ivar von Kügelgen, & Klaus Starke. (1993). Effect of opioid receptor subtype‐selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens. British Journal of Pharmacology. 108(2). 443–447. 10 indexed citations
15.
Bültmann, Ralph, et al.. (1993). Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 347(5). 527–533. 11 indexed citations
16.
Szabó, Béla, et al.. (1992). Effects of Inhibitors of Neuronal Uptake of 5-HT on Sympathetic Cardiovascular Regulation. Journal of Cardiovascular Pharmacology. 20(1). 99–107. 9 indexed citations
17.
Kügelgen, Ivar von, Ralph Bültmann, & Klaus Starke. (1989). Effects of suramin and α,β-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(6). 760–763. 50 indexed citations
18.
Szabó, Béla, et al.. (1988). ACTH increases noradrenaline release in the rabbit heart. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(4). 368–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D.J. Trezise Breakdown of academic impact, for papers by Chaoying Li Breakdown of academic impact, for papers by J. Crist Breakdown of academic impact, for papers by Angelika Meyer Breakdown of academic impact, for papers by M. Ballarín Breakdown of academic impact, for papers by Sylvester E. Vizi Breakdown of academic impact, for papers by Melanie Alexis Ruiz Breakdown of academic impact, for papers by S D Collins Breakdown of academic impact, for papers by Laura Oliveira Breakdown of academic impact, for papers by Nadine Evers
Rankless by CCL
2026